Skip to main content

Renew iv Blog


Pharmacy Compounding Committee Review: Nicotinamide Adenine Dinucleotide (NAD+)

June 17, 2021

FDA Study conducted by the FDA highlights the benefits of NAD treatment specifically reduced stress, anxiety, depression, and decreased effects of drug withdrawls.

Read the full article here:  https://www.fda.gov/media/113016/download

Welcome to the Renew iv Blog

We bring you information about wellness.

Follow us

Stay connected

Sign up for email updates to receive all of our latest news

  • This field is for validation purposes and should be left unchanged.